Protein-losing enteropathy after the Fontan operation - PubMed (original) (raw)
Protein-losing enteropathy after the Fontan operation
R H Feldt et al. J Thorac Cardiovasc Surg. 1996 Sep.
Free article
Abstract
Patients were observed after the Fontan operation to determine the frequency and severity of protein-losing enteropathy. A total of 427 patients who survived for 30 days after the Fontan operation, performed between 1973 and January 1987, were analyzed and, thus far, protein-losing enteropathy has developed in 47 of 427. The cumulative risk for the development of protein-losing enteropathy by 10 years was 13.4% among 30-day survivors, and 5-year survival after the diagnosis was 46%. Hemodynamic studies done coincident with the diagnosis of protein-losing enteropathy have shown increased systemic venous pressure, decreased cardiac index, increased pulmonary vascular resistance, and increased ventricular end-diastolic pressure. Medical management of protein-losing enteropathy was only partially successful. Statistical analysis has shown that factors related to protein-losing enteropathy were ventricular anatomy, increased preoperative ventricular end-diastolic pressure, longer operative bypass time, increased length of hospital stay, and postoperative renal failure. This study suggests that scrupulous selection of cases for the Fontan operation is mandatory and that certain perioperative factors may predispose to this serious complication of the Fontan procedure.
Similar articles
- Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation.
Ohuchi H, Yasuda K, Miyazaki A, Kitano M, Sakaguchi H, Yazaki S, Tsuda E, Yamada O. Ohuchi H, et al. Eur J Cardiothorac Surg. 2013 Mar;43(3):e49-57. doi: 10.1093/ejcts/ezs714. Eur J Cardiothorac Surg. 2013. PMID: 23396878 - Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
Lin WS, Hwang MS, Chung HT, Chu JJ, Lai MW, Yang JS, Huang SC, Huang JL, Su WJ. Lin WS, et al. Chang Gung Med J. 2006 Sep-Oct;29(5):505-12. Chang Gung Med J. 2006. PMID: 17214396 - Low pulmonary vascular compliance predisposes post-Fontan patients to protein-losing enteropathy.
Yu JJ, Yun TJ, Yun SC, Im YM, Lee SC, Shin HJ, Ko HK, Park JJ, Seo DM, Kim YH, Ko JK, Park IS. Yu JJ, et al. Int J Cardiol. 2013 May 25;165(3):454-7. doi: 10.1016/j.ijcard.2011.08.848. Epub 2011 Sep 23. Int J Cardiol. 2013. PMID: 21944467 - Protein-losing enteropathy and the Fontan operation.
Johnson JN, Driscoll DJ, O'Leary PW. Johnson JN, et al. Nutr Clin Pract. 2012 Jun;27(3):375-84. doi: 10.1177/0884533612444532. Epub 2012 Apr 19. Nutr Clin Pract. 2012. PMID: 22516942 Review. - Protein-losing enteropathy after Fontan operation.
Rychik J. Rychik J. Congenit Heart Dis. 2007 Sep-Oct;2(5):288-300. doi: 10.1111/j.1747-0803.2007.00116.x. Congenit Heart Dis. 2007. PMID: 18377444 Review.
Cited by
- Severely impaired wound healing in a Fontan patient after neurosurgery: a novel topic in univentricular heart physiology?
Kovacevic A, Schmidt KG, Schaper J, Messing-Juenger M, Hoehn T. Kovacevic A, et al. Childs Nerv Syst. 2012 Oct;28(10):1815-7. doi: 10.1007/s00381-012-1726-8. Epub 2012 Mar 1. Childs Nerv Syst. 2012. PMID: 22383164 No abstract available. - Fontan-associated protein-losing enteropathy and plastic bronchitis.
Schumacher KR, Stringer KA, Donohue JE, Yu S, Shaver A, Caruthers RL, Zikmund-Fisher BJ, Fifer C, Goldberg C, Russell MW. Schumacher KR, et al. J Pediatr. 2015 Apr;166(4):970-7. doi: 10.1016/j.jpeds.2014.12.068. Epub 2015 Feb 4. J Pediatr. 2015. PMID: 25661406 Free PMC article. - Native atrial septal restriction after Fontan palliation successfully treated with transcatheter Diabolo stent.
Aldoss O, Reinking BE, Divekar A. Aldoss O, et al. Ann Pediatr Cardiol. 2016 Jan-Apr;9(1):49-52. doi: 10.4103/0974-2069.171411. Ann Pediatr Cardiol. 2016. PMID: 27011693 Free PMC article. - Hypoplastic left heart syndrome: current considerations and expectations.
Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, Pahl E, Villafañe J, Bhatt AB, Peng LF, Johnson BA, Marsden AL, Daniels CJ, Rudd NA, Caldarone CA, Mussatto KA, Morales DL, Ivy DD, Gaynor JW, Tweddell JS, Deal BJ, Furck AK, Rosenthal GL, Ohye RG, Ghanayem NS, Cheatham JP, Tworetzky W, Martin GR. Feinstein JA, et al. J Am Coll Cardiol. 2012 Jan 3;59(1 Suppl):S1-42. doi: 10.1016/j.jacc.2011.09.022. J Am Coll Cardiol. 2012. PMID: 22192720 Free PMC article. Review. - Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.
Reller MD. Reller MD. Curr Cardiol Rep. 2001 Jan;3(1):90-5. doi: 10.1007/s11886-001-0016-y. Curr Cardiol Rep. 2001. PMID: 11139805 Review.
MeSH terms
LinkOut - more resources
Full Text Sources